BD, a leading global medical technology company, announced U.S. Food and Drug Administration approval for the use of self-collected vaginal specimens for human papillomavirus testing when cervical specimens cannot otherwise be obtained.

SPR Therapeutics announced the publication of a multicenter double-blind randomized, placebo-controlled trial of individuals experiencing moderate-to-severe postoperative pain following knee replacement and treatment with the SPRINT PNS System.

CooperCompanies, a leading global medical device company, will participate in the William Blair Growth Stock Conference on Wednesday, June 5, 2024.

Motus GI Holdings, Inc. reported its financial results for the first quarter ended March 31, 2024, and provided a corporate update.

Autonomix Medical, Inc. announced that it will participate in the Virtual Investor Closing Bell Series on Thursday, May 16, 2024 at 4:00 PM ET.

OrthAlign, Inc., a leading innovator in surgical technology, announces the launch of its flagship product, Lantern, in Japan.